Tilray Inc. (TLRY)

43.88
NASDAQ : Health Technology
Prev Close 44.79
Day Low/High 43.74 / 45.43
52 Wk Low/High 20.10 / 300.00
Avg Volume 1.64M
Exchange NASDAQ
Shares Outstanding 80.56M
Market Cap 4.35B
EPS -0.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Cannabis Stocks Fall: General Cannabis Up 3.8%; Tilray Off 4.1%

Cannabis Stocks Fall: General Cannabis Up 3.8%; Tilray Off 4.1%

Gainers trail losers two-to-nine in Cannabis sector.

China Winners and Losers: Cramer's 'Mad Money' Recap (Thursday 5/16/19)

China Winners and Losers: Cramer's 'Mad Money' Recap (Thursday 5/16/19)

Jim Cramer says Thursday's market action showed us a rally based on good old-fashioned earnings.

Aurora Cannabis Up 3.6%, General Cannabis Off 2.9%; cbdMD Due to Report

Aurora Cannabis Up 3.6%, General Cannabis Off 2.9%; cbdMD Due to Report

Gainers lead losers a day after financial results from Aurora and Tilray.

Stocks Finish Higher For Second Day on Possible Delay of Auto Tariffs

Stocks Finish Higher For Second Day on Possible Delay of Auto Tariffs

Stocks end higher following a report that the Trump administration plans to delay auto tariffs for six months.

Trimming a Position and What to Make of an Earnings Report

Energy Recovery has stabilized above our target, warranting some action. Plus, Aurora Cannabis reports earnings.

Can Aurora Cannabis Go Higher Despite Earnings Miss?

Can Aurora Cannabis Go Higher Despite Earnings Miss?

Aurora Cannabis is well off the lows, but not posting a very big move on earnings. Here are the must-know breakout and breakdown levels to watch.

One Thing Investors Need to Know Before Investing in Cannabis

One Thing Investors Need to Know Before Investing in Cannabis

Action Alerts Plus senior analyst Jeff Marks has some advice for investors looking to invest in cannabis and what they should be watching.

Three Things to Watch in the Cannabis Sector After Tilray and Aurora's Earnings

Three Things to Watch in the Cannabis Sector After Tilray and Aurora's Earnings

Curious about the cannabis sector? Here's what Tilray and Aurora's earnings mean for the sector.

What You Need to Know About the Markets, Macy's, Tilray, and Aurora Earnings

What You Need to Know About the Markets, Macy's, Tilray, and Aurora Earnings

Is the market oversold? What should investors need to know about Tilray, Aurora and Macy's earnings? Here's what investors need to know according to Action Alerts Plus senior analyst Jeff Marks and Real Money reporter Kevin Curran.

What Investors Need to Know About the Trade War, What It Means for Retail - LIVE

What Investors Need to Know About the Trade War, What It Means for Retail - LIVE

It's time to tackle the markets, and earnings from Macy's, Tilray and Aurora. Join Katherine Ross, Jeff Marks and Kevin Curran as they discuss the biggest market headlines.

Tilray Shares Jump After Q1 Revenue Beat; Aurora Slides as Sales Miss Forecasts

Tilray Shares Jump After Q1 Revenue Beat; Aurora Slides as Sales Miss Forecasts

Tilray shares traded higher Wednesday after the Canadian cannabis group posted stronger-than-expected first quarter sales, while its domestic rival Aurora Cannabis slumped after its revenues missed analysts' forecast amid caps on retail store growth in the Canadian market.

Cisco, Tilray, Aurora Cannabis, Alibaba, Trade Talks - 5 Things You Must Know

Cisco, Tilray, Aurora Cannabis, Alibaba, Trade Talks - 5 Things You Must Know

U.S. stock futures decline though sentiment gets a lift from a softening of the rhetoric from Donald Trump in the U.S.-China trade war; Cisco, Alibaba and Macy's report earnings; Tilray shares rise after the Canadian cannabis company posts a revenue beat.

Aurora Cannabis Revenue Surges 367% to C$75 Million in Fiscal Third Quarter

Aurora Cannabis Revenue Surges 367% to C$75 Million in Fiscal Third Quarter

Canadian cannabis producer says loss attributable to shareholders was C$158 million.

Tilray Climbs After Reporting 195% Jump in Revenue

Tilray Climbs After Reporting 195% Jump in Revenue

Cannabis companyposts wider loss than expected.

Tilray, Inc. Reports First Quarter 2019 Financial Results

Tilray, Inc. Reports First Quarter 2019 Financial Results

Tilray, Inc., ("Tilray" or the "Company") (Nasdaq: TLRY) a global leader in cannabis research, cultivation, production and distribution, today reported financial results for the first quarter ended March 31, 2019.

Stocks Rebound, Walmart, Roundup and Aurora Cannabis - 5 Things You Must Know

Stocks Rebound, Walmart, Roundup and Aurora Cannabis - 5 Things You Must Know

U.S. stock futures point to a modest rebound for Wall Street on Tuesday after markets reeled in the previous session as China retaliated in its trade war with the U.S.; Bayer's Monsanto loses $2 billion verdict in Roundup cancer trial; Walmart takes on Amazon with free, next-day delivery.

Earnings Preview: Take-Two, Ralph Lauren, and Tilray

Earnings Preview: Take-Two, Ralph Lauren, and Tilray

The earnings parade continues ... Here's what investors should keep their eye on in Take-Two, Ralph Lauren and Tilray earnings' reports.

Aurora Cannabis Tumbles Ahead of Earnings Report

Aurora Cannabis Tumbles Ahead of Earnings Report

Aurora Cannabis shares are falling ahead of the release of the cannabis company's earnings report Tuesday.

What's Moving the Markets, China Tariffs, Apple and Earnings Previews

What's Moving the Markets, China Tariffs, Apple and Earnings Previews

Action Alerts Plus' Senior Analyst Jeff Marks and Real Money's reporter Kevin Curran weigh in on what's moving the markets, Real Money's Stock of the Day, and look ahead to Take Two, Ralph Lauren, and Tilray earnings report.

WATCH: China Tariffs, Take Two, Ralph Lauren, and Tilray Earnings Preview

WATCH: China Tariffs, Take Two, Ralph Lauren, and Tilray Earnings Preview

Action Alerts Plus' Senior Analyst Jeff Marks and Real Money's reporter Kevin Curran weigh in on what's moving the markets, Real Money's Stock of the Day, and look ahead to Take Two, Ralph Lauren, and Tilray earnings report.

Stocks Spring Back: Cramer's 'Mad Money' Recap (Friday 5/10/19)

Stocks Spring Back: Cramer's 'Mad Money' Recap (Friday 5/10/19)

The markets staged a big reversal Friday after the China tariffs and Uber's IPO thud. Jim Cramer's got your game plan for next week.

Cronos Falls Despite Swinging to Small First-Quarter Profit

Cronos Falls Despite Swinging to Small First-Quarter Profit

Cronos shares are falling despite easily topping analysts' earnings estimates.

Http://www.highparkcompany.com

Http://www.highparkcompany.com

Tilray Inc. (NASDAQ:TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced an investment of US$32.

One-Two Punch: Cramer's 'Mad Money' Recap (Tuesday 5/7/19)

One-Two Punch: Cramer's 'Mad Money' Recap (Tuesday 5/7/19)

Jim Cramer's worried the market could reel from the tariff increases and a disappointing Uber IPO. He says investors need to brace for the possibilities.

Starbucks, DexCom, HealthEquity: 'Mad Money' Lightning Round

Starbucks, DexCom, HealthEquity: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Starbucks, DexCom, HealthEquity, Turning Point Brands, Tilray, CVS Health, Timken and more.

Tilray, Inc. To Present At The BMO Farm To Market Conference

Tilray, Inc. To Present At The BMO Farm To Market Conference

Tilray, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY), a global leader in cannabis research, cultivation, production and distribution, today announced that Brendan Kennedy, President and Chief Executive Officer, and Mark Castaneda, Chief Financial...

Ask Cramer: Cannabis ETF vs. Individual Stock: Which to Buy?

Ask Cramer: Cannabis ETF vs. Individual Stock: Which to Buy?

Should you buy cannabis ETF instead of attempting to pick an individual stock?

High Park™ Expands Supply Capacity With Sale License From Health Canada

High Park™ Expands Supply Capacity With Sale License From Health Canada

High Park Holdings Ltd. ("High Park"), a wholly-owned subsidiary of Tilray, Inc.